Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging

Future Neurology

Volumn 10, Issue 1, 2015, Pages 49-65

  Liu, Christina H ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

anatomical MRI; brain biomarkers; functional MRI; molecular MRI; MRI; MRS; neuroimaging

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON OXIDE; MANGANESE; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; ANATOMICAL CONCEPTS; BOLD SIGNAL; BRAIN ISCHEMIA; BRAIN TUMOR; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DOPAMINERGIC TRANSMISSION; ECHO PLANAR IMAGING; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENETIC ASSOCIATION; HUMAN; HYPERPOLARIZATION; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGE RECONSTRUCTION; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RADIOFREQUENCY RADIATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRACTOGRAPHY;

EID: 84920849412     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.14.60     Document Type: Review

References (97)

1. Moratal D, Valles-Luch A, Marti-Bonmati L, Brummer M. k-Space tutorial: an MRI educational tool for a better understanding of k-space. Biomed Imaging Interv. J. 4(1), e15 (2008
2. Pohmann R, Shajan G, Balla DZ. Contrast at high field: relaxation times, magnetization transfer and phase in the rat brain at 16.4 T. Magn. Reson. Med. 66(6), 1572-1581 (2011
3. The Basics of MRI, Chapter 4 NMR Spectroscopy. www.cis.rit.edu
4. The Basics of MRI, Chapter 8 Basic ImagingTechniques. www.cis.rit.edu
5. Introduction to MR image contrast: a power point presentation by Brent K Stewart PhD, DABMP at the University of Washington. www.rad.washington.edu
6. Turken AU, Herron TJ, Kant X et al Multimodal surface-based morphometry reveals diffuse cortical atrophy in traumatic brain injury. BMC Med. Imaging 31(9), 20 (2009
7. Padhani AR, Liu G, Koh DM et al Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2), 102-125 (2009
8. Metcalf M, Xu D, Okuda DT et al High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients. J. Neuroimaging 20(2), 141-147 (2010
9. De Martino F, Esposito F, Van De Moortele PF et al Whole brain high-resolution functional imaging at ultra high magnetic fields: an application to the analysis of resting state networks. Neuroimage 57(3), 1031-1044 (2011
10. Barkhof F, Pouwels PJ, Wattjes MP. The Holy Grail in diagnostic neuroradiology: 3T or 3D? Eur. Radiol. 21(3), 449-456 (2011
11. Jezzard P. Correction of geometric distortion in fMRI data. Neuroimage 62(2), 648-651 (2012
12. Feinberg DA, Setsompop K. Ultra-fast MRI of the human brain with simultaneous multi-slice imaging. J. Magn. Reson. 229, 90-100 (2013
13. Posse S, Otazo R, Dager SR, Alger J. MR spectroscopic imaging: principles and recent advances. J. Magn. Reson. Imaging 37(6), 1301-1325 (2013
14. Cai K, Haris M, Singh A et al Magnetic resonance imaging of glutamate. Nat. Med. 18(2), 302-306 (2012
15. Zhang N, Song X, Bartha R et al Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease. Curr. Alzheimer Res. (2014
16. Oz G, Alger JR, Barker PB et al Clinical proton MR spectroscopy in central nervous system disorders. Radiology 270(3), 658-679 (2014
17. Rodrigues TB, Valette J, Bouzier-Sore AK. (13)C NMR spectroscopy applications to brain energy metabolism. Front. Neuroenergetics 5, 9 (2013
18. Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin. Radiol. 64(1), 12-21 (2009
19. Liu CH, Kim YR, Ren JQ, Eichler F, Rosen BR, Liu PK. Imaging cerebral gene transcripts in live animals. J. Neurosci. 27(3), 713-722 (2007
20. Koffie RM, Farrar CT, Saidi LJ, William CM, Hyman BT, Spires-Jones TL. Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc. Natl Acad. Sci. USA 108(46), 18837-18842 (2011
21. Ahrens ET, Zhong J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed. 26(7), 860-871 (2013
22. Rajca A, Wang Y, Boska M et al Organic radical contrast agents for magnetic resonance imaging. J. Am. Chem. Soc. 134(38), 15724-15727 (2012
23. Liu CH, You Z, Liu CM et al Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains. J. Neurosci. 29(11), 3508-3517 (2009
24. Sotak CH. Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem. Int. 45(4), 569-582 (2004
25. Huisman TA. Diffusion-weighted and diffusion tensor imaging of the brain, made easy. Cancer Imaging 10, S163-S171 (2010
26. Mandeville JB, Liu CH, Vanduffel W, Marota JJ, Jenkins BG. Data collection and analysis strategies for phMRI. Neuropharmacology 84, 65-78 (2014
27. Welvaert M, Rosseel Y. A review of FMRI simulation studies. PLoS ONE 9(7), e101953 (2014
28. Kwong KK, Belliveau JW, Chesler DA et al Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl Acad. Sci. USA 89(12), 5675-5679 (1992
29. Rosazza C, Minati L, Ghielmetti F, Mandelli ML, Bruzzone MG. Functional connectivity during resting-state functional MR imaging: study of the correspondence between independent component analysis and region-of-interest-based methods. AJNR Am. J. Neuroradiol. 33(1), 180-187 (2012
30. Binnewijzend MA, Schoonheim MM, Sanz-Arigita E et al Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 33(9), 2018-2028 (2012
31. Fox MD, Greicius M. Clinical applications of resting state functional connectivity. Front. Syst. Neurosci. 4, 19 (2010
32. Biswal BB, Mennes M, Zuo XN et al Toward discovery science of human brain function. Proc. Natl Acad. Sci. USA 107(10), 4734-4739 (2010
33. Buckner RL, Krienen FM, Yeo BT. Opportunities and limitations of intrinsic functional connectivity MRI. Nat. Neurosci. 16(7), 832-837 (2013
34. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am. J. Neuroradiol. 29(7), 1228-1234 (2008
35. Alsop DC, Detre JA, Golay X et al Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn. Reson. Med. doi: 10.1002/mrm.25197. (2014) (Epub ahead of print
36. Gordon Y, Partovi S, Muller-Eschner M et al Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion. Cardiovasc. Diagn. Ther. 4(2), 147-164 (2014
37. Mandeville JB, Jenkins BG, Chen YC et al Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn. Reson. Med. 52(6), 1272-1281 (2004
38. Poline JB, Brett M. The general linear model and fMRI: does love last forever? Neuroimage 62(2), 871-880 (2012
39. D'arceuil H, Coimbra A, Triano P et al Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain. Neuroimage 83, 200-209 (2013
40. Qiu D, Zaharchuk G, Christen T, Ni WW, Moseley ME. Contrast-enhanced functional blood volume imaging (CE-fBVI): enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol. Neuroimage 62(3), 1726-1731 (2012
41. Liu CH, D'arceuil HE, De Crespigny AJ. Direct CSF injection of MnCl(2) for dynamic manganese-enhanced MRI. Magn Reson Med 51(5), 978-987 (2004
42. Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE. CEST and PARACEST MR contrast agents. Acta Radiol. 51(8), 910-923 (2010
43. Kogan F, Hariharan H, Reddy R. Chemical exchange saturation transfer (CEST) imaging: description of technique and potential clinical applications. Curr. Radiol. Rep. 1(2), 102-114 (2013
44. Ardenkjaer-Larsen JH, Fridlund B, Gram A et al Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc. Natl Acad. Sci. USA 100(18), 10158-10163 (2003
45. Bakkour A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 72(12), 1048-1055 (2009
46. Villeneuve S, Reed BR, Madison CM et al Vascular risk and Abeta interact to reduce cortical thickness in AD vulnerable brain regions. Neurology 83(1), 40-47 (2014
47. Tosun D, Schuff N, Truran-Sacrey D et al Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiol. Aging 31(8), 1340-1354 (2010
48. Lehmann M, Koedam EL, Barnes J et al Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol. Aging 33(3), 627 e621-e627 (2012
49. Gauthier LV, Taub E, Mark VW, Barghi A, Uswatte G. Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke. Stroke 43(2), 453-457 (2012
50. Jacobs HI, Visser PJ, Van Boxtel MP et al Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol. Aging 33(1), 201 e201-e208 (2012
51. Cavalieri M, Schmidt H, Schmidt R. Structural MRI in normal aging and Alzheimer's disease: white and black spots. Neurodegener. Dis. 10(1-4), 253-256 (2012
52. Zeineh MM, Holdsworth S, Skare S, Atlas SW, Bammer R. Challenges of high-resolution diffusion imaging of the human medial temporal lobe in alzheimer disease. Top. Magn. Reson. Imaging 21(6), 355-365 (2010
53. Menke RA, Jbabdi S, Miller KL, Matthews PM, Zarei M. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage 52(4), 1175-1180 (2010
54. Menke RA, Scholz J, Miller KL et al MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 47(2), 435-441 (2009
55. Stein JL, Hua X, Morra JH et al Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage 51(2), 542-554 (2010
56. Chen Y, Wolk DA, Reddin JS et al Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 77(22), 1977-1985 (2011
57. Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann. Neurol. 69(2), 269-281 (2011
58. Unschuld PG, Edden RA, Carass A et al Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Mov. Disord. 27(7), 895-902 (2012
59. Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol. Aging 32(5), 802-810 (2011
60. Kantarci K, Jack CR, Jr., Xu YC et al Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 55(2), 210-217 (2000
61. Shepherd AM, Matheson SL, Laurens KR, Carr VJ, Green MJ. Systematic meta-analysis of insula volume in schizophrenia. Biol. Psychiatry 72(9), 775-784 (2012
62. Nesvag R, Schaer M, Haukvik UK et al Reduced brain cortical folding in schizophrenia revealed in two independent samples. Schizophr. Res. 152(2-3), 333-338 (2014
63. Haukvik UK, Hartberg CB, Agartz I. Schizophrenia-what does structural MRI show? Tidsskr Nor Laegeforen 133(8), 850-853 (2013
64. Dramsdahl M, Westerhausen R, Haavik J, Hugdahl K, Plessen KJ. Adults with attention-deficit/hyperactivity disorder-A diffusion-tensor imaging study of the corpus callosum. Psychiatry Res. 201(2), 168-173 (2012
65. Canu E, Agosta F, Filippi M. A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease. Schizophr. Res. (2014
66. Liu CH, Greve DN, Dai G, Marota JJ, Mandeville JB. Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation. Neuroimage 34(3), 1042-1053 (2007
67. Schuff N, Zhang Y, Zhan W et al Patterns of altered cortical perfusion and diminished subcortical integrity in posttraumatic stress disorder: an MRI study. Neuroimage 54(Suppl. 1), S62-S68 (2011
68. Liu J, Ghassemi MM, Michael AM et al An ICA with reference approach in identification of genetic variation and associated brain networks. Front. Hum. Neurosci. 6, 21 (2012
69. Prescot AP, Renshaw PF, Yurgelun-Todd DA. gamma-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers. Drug Alcohol Depend. 129(3), 232-239 (2013
70. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30(11), 1949-1962 (2005
71. Liu CH, Ren J, Liu CM, Liu PK. Intracellular gene transcription factor protein-guided MRI by DNA aptamers in vivo. Faseb J. 28(1), 464-473 (2014
72. Liu CH, Ren JQ, Yang J et al DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J. Neurosci. 29(34), 10663-10670 (2009
73. Liu CH, Yang J, Ren JQ, Liu CM, You Z, Liu PK. MRI reveals differential effects of amphetamine exposure on neuroglia in vivo. Faseb J. 27(2), 712-724 (2013
74. Barber PA. Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit. Sensors (Basel) 13(6), 6981-7003 (2013
75. Lansberg MG, Straka M, Kemp S et al MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 11(10), 860-867 (2012
76. Grefkes C, Fink GR. Connectivity-based approaches in stroke and recovery of function. Lancet Neurol. 13(2), 206-216 (2014
77. Van Meer MP, Otte WM, Van Der Marel K et al Extent of bilateral neuronal network reorganization and functional recovery in relation to stroke severity. J. Neurosci. 32(13), 4495-4507 (2012
78. Dani KA, An L, Henning EC, Shen J, Warach S. Multivoxel MR spectroscopy in acute ischemic stroke: comparison to the stroke protocol MRI. Stroke 43(11), 2962-2967 (2012
79. Aaen GS, Holshouser BA, Sheridan C et al Magnetic resonance spectroscopy predicts outcomes for children with nonaccidental trauma. Pediatrics 125(2), 295-303 (2010
80. Sun PZ, Murata Y, Lu J, Wang X, Lo EH, Sorensen AG. Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn. Reson. Med. 59(5), 1175-1182 (2008
81. Tietze A, Blicher J, Mikkelsen IK et al Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI. NMR Biomed. 27(2), 163-174 (2014
82. Deddens LH, Van Tilborg GA, Mulder WJ, De Vries HE, Dijkhuizen RM. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies. Cerebrovasc. Dis. 33(4), 392-402 (2012
83. Ronald JA, Chen JW, Chen Y et al Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation 120(7), 592-599 (2009
84. Liu CH, Ren JQ, You Z et al Noninvasive detection of neural progenitor cells in living brains by MRI. Faseb J. 26(4), 1652-1662 (2012
85. Ellingson BM, Kim HJ, Woodworth DC et al Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271(1), 200-210 (2014
86. Gahramanov S, Muldoon LL, Varallyay CG et al Pseudoprogression of glioblastoma after chemo-and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival. Radiology 266(3), 842-852 (2013
87. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J. Clin. Oncol. 25(26), 4104-4109 (2007
88. Najafi M, Soltanian-Zadeh H, Jafari-Khouzani K, Scarpace L, Mikkelsen T. Prediction of glioblastoma multiform response to bevacizumab treatment using multi-parametric MRI. PLoS ONE 7(1), e29945 (2012
89. Abdullah KG, Lubelski D, Nucifora PG, Brem S. Use of diffusion tensor imaging in glioma resection. Neurosurg. Focus 34(4), E1 (2013
90. Abd-El-Barr MM, Saleh E, Huang RY, Golby AJ. Effect of disease and recovery on functional anatomy in brain tumor patients: insights from functional MRI and diffusion tensor imaging. Imaging Med. 5(4), 333-346 (2013
91. Saraswathy S, Crawford FW, Lamborn KR et al Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J. Neurooncol. 91(1), 69-81 (2009
92. Wijnen JP, Idema AJ, Stawicki M et al Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma. J. Magn. Reson. Imaging 36(5), 1072-1082 (2012
93. Choi C, Ganji SK, Deberardinis RJ et al 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat. Med. 18(4), 624-629 (2012
94. Zhou J, Tryggestad E, Wen Z et al Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat. Med. 17(1), 130-134 (2011
95. Chaumeil MM, Ozawa T, Park I et al Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Neuroimage 59(1), 193-201 (2012
96. Park I, Hu S, Bok R et al Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn. Reson. Med. 70(1), 33-39 (2013
97. Colen RR, Vangel M, Wang J et al Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC Med. Genomics 7, 30 (2014).